Ann Hynes
Stock Analyst at Mizuho
(4.15)
# 476
Out of 5,182 analysts
290
Total ratings
59.91%
Success rate
10.01%
Average return
Main Sectors:
Stocks Rated by Ann Hynes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BTSG BrightSpring Health Services | Maintains: Outperform | $50 → $52 | $47.27 | +10.01% | 5 | Mar 18, 2026 | |
| THC Tenet Healthcare | Maintains: Outperform | $235 → $265 | $196.64 | +34.76% | 17 | Mar 12, 2026 | |
| MOH Molina Healthcare | Maintains: Outperform | $220 → $180 | $148.97 | +20.83% | 10 | Mar 12, 2026 | |
| ELV Elevance Health | Maintains: Outperform | $413 → $350 | $323.05 | +8.34% | 7 | Mar 11, 2026 | |
| CNC Centene | Maintains: Neutral | $47 → $41 | $38.17 | +7.41% | 10 | Mar 11, 2026 | |
| SGRY Surgery Partners | Maintains: Outperform | $19 → $17 | $14.00 | +21.43% | 5 | Mar 5, 2026 | |
| HCA HCA Healthcare | Maintains: Outperform | $540 → $585 | $488.00 | +19.88% | 24 | Feb 25, 2026 | |
| CRL Charles River Laboratories International | Maintains: Neutral | $215 → $175 | $183.88 | -4.83% | 5 | Feb 20, 2026 | |
| DGX Quest Diagnostics | Maintains: Outperform | $210 → $235 | $195.02 | +20.50% | 17 | Feb 12, 2026 | |
| UNH UnitedHealth Group | Maintains: Outperform | $430 → $350 | $324.63 | +7.82% | 22 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $11 → $13 | $10.37 | +25.42% | 6 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $20 → $12 | $9.91 | +21.09% | 4 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $22 → $17 | $27.00 | -37.04% | 13 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $95 | $77.30 | +22.90% | 12 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $575 → $655 | $520.60 | +25.82% | 5 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $285 → $320 | $270.68 | +18.22% | 16 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $300 → $345 | $205.14 | +68.18% | 9 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $190 → $225 | $176.46 | +27.51% | 13 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $173 → $225 | $119.68 | +88.00% | 16 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $15 | $23.07 | -34.98% | 11 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $110 → $120 | $213.99 | -43.92% | 8 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $28 | $22.86 | +22.48% | 1 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $93 → $95 | $106.39 | -10.71% | 8 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $370 → $385 | $278.64 | +38.17% | 10 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $200 | $182.41 | +9.64% | 15 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $242 → $268 | $1.41 | +18,907.09% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $450 → $505 | $866.38 | -41.71% | 19 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $57 | $0.77 | +7,301.64% | 1 | Sep 21, 2017 |
BrightSpring Health Services
Mar 18, 2026
Maintains: Outperform
Price Target: $50 → $52
Current: $47.27
Upside: +10.01%
Tenet Healthcare
Mar 12, 2026
Maintains: Outperform
Price Target: $235 → $265
Current: $196.64
Upside: +34.76%
Molina Healthcare
Mar 12, 2026
Maintains: Outperform
Price Target: $220 → $180
Current: $148.97
Upside: +20.83%
Elevance Health
Mar 11, 2026
Maintains: Outperform
Price Target: $413 → $350
Current: $323.05
Upside: +8.34%
Centene
Mar 11, 2026
Maintains: Neutral
Price Target: $47 → $41
Current: $38.17
Upside: +7.41%
Surgery Partners
Mar 5, 2026
Maintains: Outperform
Price Target: $19 → $17
Current: $14.00
Upside: +21.43%
HCA Healthcare
Feb 25, 2026
Maintains: Outperform
Price Target: $540 → $585
Current: $488.00
Upside: +19.88%
Charles River Laboratories International
Feb 20, 2026
Maintains: Neutral
Price Target: $215 → $175
Current: $183.88
Upside: -4.83%
Quest Diagnostics
Feb 12, 2026
Maintains: Outperform
Price Target: $210 → $235
Current: $195.02
Upside: +20.50%
UnitedHealth Group
Feb 5, 2026
Maintains: Outperform
Price Target: $430 → $350
Current: $324.63
Upside: +7.82%
Dec 18, 2025
Maintains: Neutral
Price Target: $11 → $13
Current: $10.37
Upside: +25.42%
Dec 18, 2025
Maintains: Outperform
Price Target: $20 → $12
Current: $9.91
Upside: +21.09%
Dec 18, 2025
Maintains: Neutral
Price Target: $22 → $17
Current: $27.00
Upside: -37.04%
Dec 10, 2025
Maintains: Outperform
Price Target: $88 → $95
Current: $77.30
Upside: +22.90%
Oct 24, 2025
Maintains: Outperform
Price Target: $575 → $655
Current: $520.60
Upside: +25.82%
Oct 17, 2025
Maintains: Outperform
Price Target: $285 → $320
Current: $270.68
Upside: +18.22%
Oct 9, 2025
Maintains: Outperform
Price Target: $300 → $345
Current: $205.14
Upside: +68.18%
Jul 25, 2025
Maintains: Outperform
Price Target: $190 → $225
Current: $176.46
Upside: +27.51%
Jul 25, 2025
Maintains: Outperform
Price Target: $173 → $225
Current: $119.68
Upside: +88.00%
Nov 19, 2024
Maintains: Neutral
Price Target: $13 → $15
Current: $23.07
Upside: -34.98%
Nov 4, 2024
Maintains: Neutral
Price Target: $110 → $120
Current: $213.99
Upside: -43.92%
Aug 19, 2024
Initiates: Outperform
Price Target: $28
Current: $22.86
Upside: +22.48%
Apr 25, 2024
Maintains: Buy
Price Target: $93 → $95
Current: $106.39
Upside: -10.71%
Mar 8, 2024
Maintains: Buy
Price Target: $370 → $385
Current: $278.64
Upside: +38.17%
Mar 6, 2024
Maintains: Buy
Price Target: $175 → $200
Current: $182.41
Upside: +9.64%
Feb 23, 2024
Maintains: Buy
Price Target: $242 → $268
Current: $1.41
Upside: +18,907.09%
Feb 9, 2024
Maintains: Neutral
Price Target: $450 → $505
Current: $866.38
Upside: -41.71%
Sep 21, 2017
Initiates: Neutral
Price Target: $57
Current: $0.77
Upside: +7,301.64%